Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05977322
Title A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ESP

Facility Status City State Zip Country Details
Novartis Investigative Site RECRUITING Tel Aviv 6423906 Israel Details
Novartis Investigative Site RECRUITING Nijmegen Netherland 6525 GA Netherlands Details
Novartis Investigative Site RECRUITING Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site RECRUITING Madrid 28034 Spain Details
Novartis Investigative Site RECRUITING Geneve 14 CH 1211 Switzerland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field